The death of the 18-year-old from Sestri Levante suffering from thrombosis after the first dose of Astrazeneca vaccine is “dramatic news”. “I wonder: how is it possible that the initiative was taken to give this vaccine in this age group, beyond the existing recommendations? Was the CTS informed? It had to be consulted before, not after”. To tell Adnkronos Salute is the virologist Andrea Crisanti.
“I am amazed that the initiative to organize Astraday for 18 year olds was taken without the advice of a scientific expertise. We consider that between 10 and 19 years of age there have been 6 Covid deaths of women in Italy. Now we have one death after vaccination with an adenoviral vector vaccine. The game is not worth it “, reflects the director of the Department of Molecular Medicine of the University of Padua. “It is useless to hide behind the fact that in Italy a preferential use has been indicated for the vaccine in question over the age of 60. Preferential, when you have so many vaccines available, is equivalent to mandatory, let’s not fool ourselves. about it. If you have alternatives, don’t give it. Vax days had to be done with other vaccines “.
“The problem now arises of the booster for children who have received the first dose of AstraZeneca vaccine. I would wait. As for the second dose with a different vaccine – he underlines – I keep repeating that without data you cannot vaccinate. From a point from an immunological point of view there would be no contraindications to do the second dose with a different vaccine, but since there are no data I remain of the idea that we must have them in hand before proceeding. Although personally I do not think there would be a risk of any kind, it is a question of not being apprentice sorcerers. This is not the banana republic. Who takes the responsibility of boostering with a different vaccine without enough data? You have to be consistent with the method “.
“So now for the children vaccinated with the first dose of AstraZeneca – he remarks – I would wait with the recall and would call them back around October-November. I would wait to have the data confirming that there are no dangers in making a second dose with a different vaccine. this”.
–
